-
Mashup Score: 0PH Community Workshop – Houston - 2 month(s) ago
Join us in Houston for a free workshop on managing and thriving with pulmonary hypertension.
Source: phassociation.orgCategories: General Medicine News, Rare DiseaseTweet
-
Mashup Score: 47
MCJ deficiency preserves the right ventricular function after hypoxia-induced pulmonary hypertension.
Source: www.science.orgCategories: General Medicine News, General NewsTweet-
Scientists discover first therapeutic target for preserving heart function in patients with #pulmonaryHypertension @ScienceAdvances https://t.co/fRNZ75pfHo https://t.co/SDn5SthjEb
-
-
Mashup Score: 9
BACKGROUND: Hypoxia is a major cause and promoter of pulmonary hypertension (PH), a representative vascular remodeling disease with poor prognosis and high mortality. However, the mechanism underlyin
Source: www.ahajournals.orgCategories: Cardiology News and Journals, Latest HeadlinesTweet-
Zhou et al found that by maintaining endothelial #mitochondrial homeostasis #deSUMOylation of #FIS1 adaptively preserves #endothelial function against hypoxic stress and consequently protects against #PulmonaryHypertension. Learn more at https://t.co/PVvcZOQYHh https://t.co/PcoyXDEWvX
-
-
Mashup Score: 0Human Plasma IgG N-Glycome Profiles Reveal a Proinflammatory Phenotype in Chronic Thromboembolic Pulmonary Hypertension - 8 month(s) ago
BACKGROUND: The pathological mechanism of chronic thromboembolic pulmonary hypertension (CTEPH) is not fully understood, and inflammation has been reported to be one of its etiological factors. IgG r
Source: www.ahajournals.orgCategories: Cardiology News and Journals, Latest HeadlinesTweet-
Signature of plasma IgG N-glycome in patients with chronic thromboembolic pulmonary hypertension, showing the dysregulated and pro-inflammatory phenotype of IgG N-glycome in this disease @Jing_ZhiCheng@Jing_ZhiCheng #PulmonaryHypertension. Pictured: Aut... https://t.co/IFi5XyoAJy https://t.co/d08X5houVq
-
-
Mashup Score: 1Chronic thromboembolic pulmonary hypertension: realising the potential of multimodal management - 8 month(s) ago
Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare complication of acute pulmonary embolism. Important advances have enabled better understanding, characterisation, and treatment of this condition. Guidelines recommending systematic follow-up after acute pulmonary embolism, and the insight that CTEPH can mimic acute pulmonary embolism on initial presentation, have led to the definition of CTEPH imaging characteristics, the introduction of artificial intelligence diagnosis pathways, and thus the prospect of easier and earlier CTEPH diagnosis.
Source: www.thelancet.comCategories: Latest Headlines, PulmonologyTweet-
@madelcroix and colleagues describe treatment modalities targeting major vessel obstructions and microvasculopathy in chronic thromboembolic #PulmonaryHypertension, and outline a multimodal approach to management https://t.co/inoLsO3wBp #PH #CTEPH #PulmonaryEmbolism https://t.co/c9cHGYheMi
-
-
Mashup Score: 14Pulmonary Hypertension 2023 - 8 month(s) ago
The field of pulmonary hypertension has been transformed by advances in understanding of pathophysiological mechanisms and the development of a wide range of therapeutic options. The five main groups of pulmonary hypertension differ in epidemiology, causes and risk factors, underlying disease mechanisms, and clinical presentation. Approaches to diagnosis and management reflect the distinctive features of each condition. In the first of a Series of three papers, Marc Humbert and colleagues provide an
Source: www.thelancet.comCategories: Latest Headlines, PulmonologyTweet-
The field of #pulmonaryhypertension has been transformed by advances in understanding of pathophysiological mechanisms and the development of a wide range of #therapeutic options Find out more in a new @LancetRespirMed Series https://t.co/ALcvKnFvoM #PH #PAH #CTEPH #COPD #ILD https://t.co/9xiHMp5yO4
-
-
Mashup Score: 3Treatment of pulmonary arterial hypertension: recent progress and a look to the future - 8 month(s) ago
Pulmonary arterial hypertension (PAH) is a severe but treatable form of pre-capillary pulmonary hypertension caused by pulmonary vascular remodelling. As a result of basic science discoveries, randomised controlled trials, studies of real-world data, and the development of clinical practice guidelines, considerable progress has been made in the treatment options and outcomes for patients with PAH, underscoring the importance of seamless translation of information from bench to bedside and, ultimately, to patients.
Source: www.thelancet.comCategories: Latest Headlines, PulmonologyTweet-
Marc Humbert, @AlbertaPHdoc, and colleagues review recent progress and consider future directions for the treatment of #PulmonaryArterialHypertension https://t.co/OWWR9YYnvq #PulmonaryHypertension #PH #PAH https://t.co/gBQkW9cT3j
-
-
Mashup Score: 0Pulmonary hypertension associated with lung disease: new insights into pathomechanisms, diagnosis, and management - 8 month(s) ago
Patients with chronic lung diseases, particularly interstitial lung disease and chronic obstructive pulmonary disease, frequently develop pulmonary hypertension, which results in clinical deterioration, worsening of oxygen uptake, and an increased mortality risk. Pulmonary hypertension can develop and progress independently from the underlying lung disease. The pulmonary vasculopathy is distinct from that of other forms of pulmonary hypertension, with vascular ablation due to loss of small pulmonary vessels being a key feature.
Source: www.thelancet.comCategories: Latest Headlines, PulmonologyTweet-
Karen Olsson and colleagues emphasise the pressing need for safe, effective treatment options and non-invasive diagnostic tools to detect and characterise #PulmonaryHypertension in patients with chronic lung disease https://t.co/yeHFOQ6DyM #PH #COPD #ILD #CPFE https://t.co/vfpkdVpv93
-
-
Mashup Score: 2
Abstract Background Current cardiac magnetic resonance (CMR) imaging in pulmonary arterial hypertension (PAH) focuses on measures of ventricular function and coupling. Objectives The purpose of thi…
Source: www.jacc.orgCategories: Latest Headlines, Partners & KOLsTweet-
New issue of #JACCIMG is out! Novel #whyCMR feature tracked PA global longitudinal strain ➡️ incremental prognostic utility over established risk scores for #PulmonaryHypertension patients at higher risk of death. https://t.co/bNgEbZh2Ll #cvPAH #CardioTwitter @smrabd https://t.co/Es9WgrG6dh
-
-
Mashup Score: 0
The Pulmonary Hypertension Association’s PH Professional Network (PHPN) Symposium brings together hundreds of allied health care professionals every two years to network and earn continuing education credits.
Source: symposium.phassociation.orgCategories: Latest Headlines, Rare DiseaseTweet-
Register now for the @PHAssociation's 2023 #PH Professional Network Symposium. Join virtually or in-person September 28-30 in Arlington, VA to network, learn the latest in #PulmonaryHypertension research and care, and earn 11.0 CE credits! Register here: https://t.co/yIHlxfNONg
-
Don’t miss the @PHAssociation's weekend of education, connection and empowerment on April 6-7, in Houston! The weekend will feature the PHA Connects: PH Community Workshop on Saturday and the 2024 Houston O2breathe Walk on Sunday. #PulmonaryHypertension https://t.co/wYB2uIpheF